BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19123725)

  • 1. College of American Pathologists protocol for the reporting of ductal carcinoma in situ.
    Lester SC; Connolly JL; Amin MB
    Arch Pathol Lab Med; 2009 Jan; 133(1):13-4. PubMed ID: 19123725
    [No Abstract]   [Full Text] [Related]  

  • 2. Examination of specimens from patients with ductal carcinoma in situ of the breast using large-format histology sections.
    Tot T; Ibarra JA
    Arch Pathol Lab Med; 2009 Sep; 133(9):1361; author reply 1361-2. PubMed ID: 19722732
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
    Lester SC; Bose S; Chen YY; Connolly JL; de Baca ME; Fitzgibbons PL; Hayes DF; Kleer C; O'Malley FP; Page DL; Smith BL; Weaver DL; Winer E;
    Arch Pathol Lab Med; 2009 Jan; 133(1):15-25. PubMed ID: 19123730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synoptic report of the American College of Pathologists and the Polish Society of Pathologists - version 2014 ].
    Olszewski W; Chmielik E
    Pol J Pathol; 2014 Dec; 65(4 Suppl 2):S21-31. PubMed ID: 26165041
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.
    J Clin Pathol; 1991 Sep; 44(9):710-25. PubMed ID: 1655830
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W
    Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
    Purcell CA; Norris HJ
    Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.
    Schnitt SJ; Brogi E; Chen YY; King TA; Lakhani SR
    Ann Diagn Pathol; 2020 Apr; 45():151481. PubMed ID: 32120324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ of the breast.
    Bruetman D; Bloom K; Bines S
    Med Pediatr Oncol; 1989; 17(3):227-31. PubMed ID: 2546028
    [No Abstract]   [Full Text] [Related]  

  • 10. Ductal carcinoma in situ of the breast.
    Layfield LJ
    Hum Pathol; 1998 Nov; 29(11):1329-32. PubMed ID: 9824118
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer.
    Coleman WB
    Am J Pathol; 2019 May; 189(5):942-945. PubMed ID: 31029232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice protocol for the examination of specimens removed from patients with cancer of the breast: a publication of the Cancer Committee, College of American Pathologists. Members of the Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens from Patients with Breast Cancer.
    Henson DE; Oberman HA; Hutter RV
    Arch Pathol Lab Med; 1997 Jan; 121(1):27-33. PubMed ID: 9111089
    [No Abstract]   [Full Text] [Related]  

  • 13. Human Ductal Carcinoma In Situ: from the Eyes of a Beholder.
    Herschkowitz JI; Behbod F
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):189-190. PubMed ID: 30406903
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis.
    O'Keefe TJ; Wallace AM
    Breast Cancer Res Treat; 2020 Aug; 182(3):761-762. PubMed ID: 32529407
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign epithelial proliferations in axillary lymph nodes with ipsilateral breast in situ ductal carcinoma and intraductal papilloma of the breast.
    Liu M
    Histopathology; 2008 May; 52(6):771-3. PubMed ID: 18439159
    [No Abstract]   [Full Text] [Related]  

  • 16. Ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Schnitt SJ; Silen W; Sadowsky NL; Connolly JL; Harris JR
    N Engl J Med; 1988 Apr; 318(14):898-903. PubMed ID: 2832757
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Schwartz GF; Lagios MD; Silverstein MJ
    J Natl Cancer Inst; 2004 Aug; 96(16):1258-9; author reply 1259-60. PubMed ID: 15316064
    [No Abstract]   [Full Text] [Related]  

  • 18. Ductal carcinoma in situ.
    Swain SM
    Cancer Invest; 1992; 10(5):443-54. PubMed ID: 1327429
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer pathology.
    Lee CS
    Pathology; 2005 Oct; 37(5):339-40. PubMed ID: 16194842
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of margins in invasive carcinoma and ductal carcinoma in situ: The pathologist's perspective.
    Schnitt SJ
    Breast; 2017 Aug; 34 Suppl 1():S58-S60. PubMed ID: 28663004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.